Compare MGYR & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | RCEL |
|---|---|---|
| Founded | 1922 | N/A |
| Country | United States | United States |
| Employees | N/A | 226 |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.3M | 126.8M |
| IPO Year | 2021 | N/A |
| Metric | MGYR | RCEL |
|---|---|---|
| Price | $17.49 | $5.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.88 |
| AVG Volume (30 Days) | 3.2K | ★ 358.7K |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 26.83 | N/A |
| EPS | ★ 0.98 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $49.82 |
| P/E Ratio | $17.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.03 | $3.22 |
| 52 Week High | $20.00 | $7.12 |
| Indicator | MGYR | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 52.27 | 61.76 |
| Support Level | $16.80 | $3.55 |
| Resistance Level | $17.69 | $5.32 |
| Average True Range (ATR) | 0.23 | 0.45 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 59.21 | 65.18 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.